![]() |
Media release "Low
tar" brand misled smoker
Jury orders Philip Morris to pay family AUD$282m in punitive damages
|
March 25, 2002 |
| Back to Media Releases index |
“
The
family of a woman who died of lung cancer after smoking low-tar
cigarettes has won a AUD$282m punitive damages verdict against tobacco
giant Philip Morris. The
jury in Oregon, USA found cigarettes marketed as low-tar are just as
dangerous as regular cigarettes – and that the company had falsely
represented its brand as healthier. The
court heard that nicotine-addicted smokers tend to puff harder at
so-called “light” or “mild” brands, and smoke them further
down to the filter – resulting in the absorption of at least as much
tar as from standard cigarettes. The
damages award was made to the estate of Michelle Schwarz of Salem,
USA, who died of lung cancer in 1999 at the age of 53 after smoking
low-tar “Merit” cigarettes. Philip
Morris says it will appeal - arguing that it did not claim the low-tar
brand was healthier, only “milder.” Says
Anne Jones, CEO of ASH Australia: “’Light’ cigarettes are a
consumer fraud to keep people smoking – rather than quitting,
smokers are conned instead into smoking ‘light’ or ‘mild’
cigarettes, believing them to be healthier. “It’s
a matter of urgency that governments and the Australian Competition
and Consumer Commission take action to end all forms of misleading and
deceptive conduct by tobacco manufacturers
operating in Australia – including Philip Morris.” More
on the case at www.tobacco.neu.edu A
US government study released last year showed that lung cancer death
rates had risen in the US since the introduction of low-tar brands in
the 1960s. The
National Cancer Institute study found that many of these brands were
deceptive in their intent, and were designed to show low tar readings
on tests using machines which took regular, even puffs – whereas
addicted smokers were known by the companies to puff harder and more
deeply seeking the same level of nicotine. See
the study at http://cancercontrol.cancer.gov/tcrb/nci_monographs/MONO13/M13.PDF Comment:
Anne Jones, ph.
(02) 9334-1876 or
(m) 0417-227-879
Media
inquiries: Stafford
Sanders
ph. (02) 9334-1823
|
|
|
Page last updated on 25/3/2002 |
||